Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents

Compounds of general formula I,

• wherein
• R1 stands for linear or branched C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl, C1-C6-alkoxy, C1-C6-alkylthio or C3-C12-cycloalkyl, C3-C12-cycloalkenyl, C3-C12-heterocycloalkyl, C3-C12-heterocycloalkenyl, aryl or heteroaryl, which optionally can be substituted,
• R2 and R3 are the same or different and stand for hydrogen, linear or branched C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl or C1-C6-alkoxy, which optionally can be substituted,
• R4 and R5 are the same or different and stand for hydrogen, halogen, linear or branched C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl or C1-C6-alkoxy, which optionally can be substituted, or together stand for a carbonyl group, or together form a cyclic five- or six-ring-acetal with O,O;
• N,O;
• O,S;
• or S,S, which optionally can be substituted with C1-C6-alkyl, or
• R2 and R4 together form a C3-C12-cycloalkyl ring or a C3-C12-cycloalkenyl ring, which optionally can be substituted,
• R6 and R7 are the same or different and stand for hydrogen, linear or branched C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkinyl, which optionally can be substituted, or together form a C3-C12-cycloalkyl ring or a C3-C12-cycloalkenyl ring, which optionally can be substituted, or
• R5 and R6 optionally together form a double bond, or
• R3 and R5 together form a C3-C12-cycloalkyl ring or a C3-C12-cycloalkenyl ring, which optionally can be substituted,
• T stands for —CH2—, —O—, —CH2═CH2—, —CH≡CH—, —CH2—O—CH2—, —CH2—O—, —O—CH2— or ═CO, and
• n stands for 0-6, or a tautomer, isomer or salt thereof.